JUPITER, Fla.--(BUSINESS WIRE)--Dyadic International, Inc. (AMEX:DIL), a biotechnology company, today announced financial results for the third quarter ended September 30, 2006, highlighted by a notable increase in sales of the Company’s proprietary enzymes to customers in the pulp and paper industry, effective cost management resulting in a strong closing cash balance, and improved gross margin as compared to the third quarter of 2005.
